title: Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies.
authors.forename: J T
authors.initials: JT
authors.lastname: Backstrom
authors.forename: R L
authors.initials: RL
authors.lastname: Hinkle
authors.forename: M R
authors.initials: MR
authors.lastname: Flicker
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects*; D006801:Humans; D011358:Product Surveillance, Postmarketing; D020888:Vigabatrin; D014786:Vision Disorders / Q000139:chemically induced; D014794:Visual Fields; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin